We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisers Recommend Approval of Diabetes Drug Exubera
FDA Advisers Recommend Approval of Diabetes Drug Exubera
September 9, 2005
The potential breakthrough diabetes drug Exubera, developed by Pfizer and sanofi-aventis, has received the green light from an FDA advisory panel, which voted 7-2 Sept. 8 to recommend approval for the inhaled insulin powder.